1. In vitro three-dimensional cell cultures for bone sarcomas
   Javier Munoz-Garcia et al, 2021, Journal of Bone Oncology CrossRef
2. Molecular Genetics of Ewing Sarcoma
   José L Ordóñez et al, 2015, Encyclopedia of Life Sciences CrossRef
3. Cancer stem cells in sarcomas: Getting to the stemness core
   Jan Skoda et al, 2018, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
4. Pediatric sarcomas (Review)
   Junhua Cao et al, 2017, Oncology Letters CrossRef
5. Experimental Models
   Susanne A. Gatz et al, 2021, Sarcomas of Bone and Soft Tissues in Children and Adolescents CrossRef
6. Cancer Stem Cells and Chemoresistance in Ewing Sarcoma
   Rafael Pereira dos Santos et al, 2023, Current Stem Cell Research & Therapy CrossRef
7. Insulin‐like growth factor‐1 receptor (IGF‐1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells
   Silke Jamitzky et al, 2015, Pediatric Blood & Cancer CrossRef
8. Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma
   Bárbara Kunzler Souza et al, 2018, Molecular Neurobiology CrossRef
9. PDX-Derived Ewing’s Sarcoma Cells Retain High Viability and Disease Phenotype in Alginate Encapsulated Spheroid Cultures
   Giacomo Domenici et al, 2021, Cancers CrossRef
10. Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review
    Maria Angeles Chico et al, 2023, Cancers CrossRef
11. The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
    Philipp Berning et al, 2018, Cell Communication and Signaling CrossRef
12. Splice variants denote differences between a cancer stem cell side population of EWSR1‑ERG‑based Ewing sarcoma cells, its main population and EWSR1‑FLI‑based cells
    Eberhard Korsching et al, 2022, International Journal of Molecular Medicine CrossRef
13. Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
    Sareetha Kailayangiri et al, 2017, OncoImmunology CrossRef
14. Cancer stem cells and clonal evolution in bone sarcomas
    René Rodríguez et al, 2022, Bone Cancer CrossRef
15. EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
    Sareetha Kailayangiri et al, 2019, Molecular Therapy CrossRef
16. Modeling neoplastic disease with spheroids and organoids
    Michele Zanoni et al, 2020, Journal of Hematology & Oncology CrossRef
17. Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma
    Frank Eckerdt et al, 2019, Scientific Reports CrossRef
18. Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells
    Tomohiro Fujiwara et al, 2016, Stem Cells International CrossRef